Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Edderd who wrote (3919)	12/19/1997 10:00:00 PM
From: LoLoLoLita	Read Replies (1) \| Respond to of 23519

Edderd, I'm sure that you're right for ED. But my interest was more focused on the "recreational" uses of yohimbine by "healthy" males who desired to go bigger, harder, longer, and were willing to tolerate the side effects associated with a 3-tablet (16.2 mg) dose. The new slant to the discussion that I tried to introduce last night was motivated by my curiosity as to whether the social acceptance of ED drugs without stigma could possibly lead to their use by healthy individuals wishing to enhance their already "adequate" performance. I agree that Muse and Caverject might never be used in this way, but yohimbine already is (go to most any large health food store and you'll see a big shelf full of the extracts), and Viagra may come to be used that way as well. Just a few years ago, my experience was that ED (or "impotence") was a thing that caused the sufferers to feel shame, and many undoubtedly never raised it with their doctors. This now seems to be abating somewhat, judging from the discussions I've seen on the internet, probably spurred along by the new treatments. And, if this trend continues, as I expect it will, we should see more and more ED sufferers get "off the couch and in to see their doctor." And some will end up with Muse. I don't need a reply. All of what I said has been said before. David